Company / Operating Cash Flow per Share
Bionano Genomics, Inc. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$8.76
FY2025
5-year range
-$90.39 / -$0.38
FY2021-FY2025
Trend
+90.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share returned to growth in FY2025 after 3 years of decline, reaching $-8.76.
Based on SEC 10-K filings.
-8.76 in FY2025.
Declined from $-4.21 to $-8.76 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 90.3% year-over-year.
- Peak operating cash flow per share was recorded in FY2021.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$8.76 | +90.3% |
| FY2024 | -$90.39 | -2045.8% |
| FY2023 | -$4.21 | -877.4% |
| FY2022 | -$0.43 | -13.8% |
| FY2021 | -$0.38 | +66.1% |
| FY2020 | -$1.12 | +61.9% |
| FY2019 | -$2.94 | +98.9% |
| FY2018 | -$258.15 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026